Skip to main content

Research Repository

Advanced Search

All Outputs (3)

Neuraminidase inhibitors: who, when, where? (2014)
Journal Article
Nguyen-Van-Tam, J. S., Venkatesan, S., Muthuri, S. G., & Myles, P. R. (2015). Neuraminidase inhibitors: who, when, where?. Clinical Microbiology and Infection, 21(3), https://doi.org/10.1016/j.cmi.2014.11.020

Although the neuraminidase inhibitors (NIs), oseltamivir and zanamivir were first licensed in 1999, their clinical effectiveness is still hotly debated. Two rigorous systematic reviews and meta-analyses of the data from clinical trials conducted in c... Read More about Neuraminidase inhibitors: who, when, where?.

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data (2014)
Journal Article
Muthuri, S. G., Venkatesan, S., Myles, P. R., Leonardi-Bee, J., Al Khuwaitir, T. S., Al Mamun, A., …Nguyen-Van-Tam, J. (2014). Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respiratory Medicine, 2(5), https://doi.org/10.1016/S2213-2600%2814%2970041-4

Neuraminidase inhibitors were widely used during the 2009/10 influenza A H1N1 pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We did a meta-analysis of individual participant data to investigate the association betw... Read More about Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.